| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma (NCT05116800) | Brown University | 2022-03-01 |
| Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors (NCT05302921) | Children's National Research Institute | 2022-02-18 |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (NCT04995003) | Baylor College of Medicine | 2021-12-07 |
| A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors (NCT05093322) | Hutchmed | 2021-11-30 |
| Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors (NCT04337177) | Valent Technologies, LLC | 2021-10-25 |
| A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas (NCT04906876) | Brown University | 2021-09-01 |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (NCT04377932) | Baylor College of Medicine | 2021-08-08 |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors (NCT05103631) | Baylor College of Medicine | 2021-06-17 |
| A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (NCT04730349) | Bristol-Myers Squibb | 2021-06-03 |
| Indo-cyanine Green (ICG) in Paediatric Oncology MIS (NCT04854018) | Birmingham Women's and Children's NHS Foundation Trust | 2021-04-30 |
| PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine (NCT05697198) | Labcorp Corporation of America Holdings, Inc | 2021-04-19 |
| Drug Sensitivity and Mutation Profiling (NCT04956198) | Florida International University | 2020-11-17 |
| FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma (NCT04625907) | University of Birmingham | 2020-09-17 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma (NCT04299113) | Jonsson Comprehensive Cancer Center | 2020-05-14 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors (NCT03709680) | Pfizer | 2019-05-24 |
| Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas (NCT03478462) | Cellectar Biosciences, Inc. | 2019-04-30 |
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 (NCT02890758) | Brenda Cooper, MD | 2018-05-22 |
| Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (NCT03458728) | Bayer | 2018-04-30 |
| Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) (NCT03496402) | Institut Curie | 2018-04-20 |
| Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors (NCT03245450) | Eisai Inc. | 2018-03-05 |
| Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients (NCT03462888) | Centre Oscar Lambret | 2018-02-02 |
| Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035) | National Cancer Institute (NCI) | 2017-11-08 |
| Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma (NCT03041701) | National Cancer Institute (NCI) | 2017-07-07 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas (NCT03054792) | The Hospital for Sick Children | 2017-05-01 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies (NCT04308330) | New York Medical College | 2017-03-17 |
| A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors. (NCT06836492) | Yizhuo Zhang | 2017-01-30 |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors (NCT02581384) | Dana-Farber Cancer Institute | 2017-01-01 |
| HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors (NCT02557854) | Theodore Laetsch | 2016-12-01 |
| Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors (NCT02982941) | MacroGenics | 2016-12-01 |
| Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma (NCT02945800) | H. Lee Moffitt Cancer Center and Research Institute | 2016-10-25 |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors (NCT02536183) | AeRang Kim | 2016-10-01 |
| Impact of an Orthotic Intervention in Children With Peripheral Neuropathy (NCT03655587) | Children's Hospitals and Clinics of Minnesota | 2016-09-20 |
| Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors (NCT02689336) | Washington University School of Medicine | 2016-08-06 |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) (NCT02624388) | University of Virginia | 2016-08-01 |
| Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma (NCT02567435) | National Cancer Institute (NCI) | 2016-06-01 |
| Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors (NCT02508038) | University of Wisconsin, Madison | 2016-02-12 |
| A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping (NCT02509598) | Cardinal Health 414, LLC | 2015-08-01 |
| Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas (NCT02415816) | St. Jude Children's Research Hospital | 2015-06-05 |
| Trial of Afatinib in Pediatric Tumours (NCT02372006) | Boehringer Ingelheim | 2015-04-29 |
| TAA-Specific CTLS for Solid Tumors (TACTASOM) (NCT02239861) | Baylor College of Medicine | 2015-04-01 |
| Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (NCT02390843) | Emory University | 2015-02-01 |
| Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas (NCT02409576) | National University Hospital, Singapore | 2015-02-01 |
| SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes (NCT02048371) | Sarcoma Alliance for Research through Collaboration | 2014-07-01 |
| Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors (NCT02011126) | Children's Oncology Group | 2014-06-30 |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors (NCT02076906) | AeRang Kim | 2014-04-01 |
| Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy (NCT01871766) | St. Jude Children's Research Hospital | 2013-12-04 |
| Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors (NCT01962103) | Celgene | 2013-12-04 |
| Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors (NCT02013336) | South Plains Oncology Consortium | 2013-12-01 |
| A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma (NCT01697514) | Eli Lilly and Company | 2013-07-01 |
| Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma (NCT01858168) | Massachusetts General Hospital | 2013-07-01 |
| Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors (NCT01807468) | Samsung Medical Center | 2013-05-01 |
| Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors (NCT02100891) | Monica Thakar | 2013-03-20 |
| Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors (NCT01661400) | Washington University School of Medicine | 2012-10-26 |
| Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy (NCT01674101) | St. Jude Children's Research Hospital | 2012-09-01 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas (NCT01625351) | St. Jude Children's Research Hospital | 2012-08-20 |
| Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma (NCT01614795) | National Cancer Institute (NCI) | 2012-06-18 |
| Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma (NCT01355445) | Centre Oscar Lambret | 2012-01-01 |
| Auto Transplant for High Risk or Relapsed Solid or CNS Tumors (NCT01505569) | Masonic Cancer Center, University of Minnesota | 2011-10-20 |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI (NCT01336803) | Heike E Daldrup-Link | 2011-08-01 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB (NCT01125800) | Novartis Pharmaceuticals | 2011-02-01 |
| Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma (NCT01241162) | University of Louisville | 2010-08-01 |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients (NCT01169584) | Jennerex Biotherapeutics | 2010-08-01 |
| Markers of Anthracycline-Related Cardiac Muscle Injury (NCT01112800) | St. Jude Children's Research Hospital | 2010-05-01 |
| HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors (NCT00931931) | Timothy Cripe | 2010-03-01 |
| Methionine PET/CT Studies In Patients With Cancer (NCT00840047) | St. Jude Children's Research Hospital | 2009-07-20 |
| A Vaccine Study for High Risk Cancers (NCT00944580) | Penn State University | 2009-06-01 |
| A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma (NCT00668148) | Eli Lilly and Company | 2008-07-01 |
| A Study of Pemetrexed in Children With Recurrent Cancer (NCT00520936) | Eli Lilly and Company | 2007-09-01 |
| Trial of Dasatinib in Advanced Sarcomas (NCT00464620) | Sarcoma Alliance for Research through Collaboration | 2007-05-01 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma (NCT00354835) | Children's Oncology Group | 2006-12-26 |
| HGS-ETR2 to Treat Children With Solid Tumors (NCT00428272) | National Cancer Institute (NCI) | 2006-12-04 |
| Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors (NCT00187174) | St. Jude Children's Research Hospital | 2004-10-01 |
| Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma (NCT00592592) | Massachusetts General Hospital | 2004-10-01 |
| Radiation Therapy to Treat Musculoskeletal Tumors (NCT00186992) | St. Jude Children's Research Hospital | 2003-01-10 |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy (NCT00187109) | St. Jude Children's Research Hospital | 2000-06-01 |
| Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy (NCT00004853) | National Cancer Institute (NCI) | 2000-03-03 |
| Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma (NCT00919269) | Children's Oncology Group | 1999-03-15 |
| Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases (NCT00001686) | National Cancer Institute (NCI) | 1998-03-19 |
| A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas (NCT00001564) | National Cancer Institute (NCI) | 1996-12-23 |
| A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas (NCT00001566) | National Cancer Institute (NCI) | 1996-12-01 |
| Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood (NCT00162695) | Gustave Roussy, Cancer Campus, Grand Paris | 1995-07-01 |
| New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma (NCT00001335) | National Cancer Institute (NCI) | 1993-04-01 |
| EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children (NCT00339118) | Sheba Medical Center | |